SUBSCRIBE
SUBSCRIBE
News   Business

AEterna Zentaris 1Q Loss Narrows as Costs Dwindle

May 13, 2010 | 
1 min read

Business Week -- Canadian biopharmaceutical company AEterna Zentaris Inc. said Thursday its first-quarter loss narrowed on lower research and development costs.

Earnings
MORE ON THIS TOPIC
Facade of Novo Nordisk's office in Fremont, California
Manufacturing
Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion, $200M Plant Purchase
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Business
Previous Investment Patterns Set to Repeat in 2025
December 5, 2024
 · 
1 min read
 · 
Lori Ellis
GSK's headquarters office building in Poznan, Poland
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
 · 
1 min read
 · 
Kate Goodwin
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
 · 
2 min read
 · 
Heather McKenzie